- Home
- ADPT vs RAMP Comparison
ADPT vs RAMP Comparison
Compare ADPT & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- RAMP
- Stock Information
- Founded
- ADPT 2009
- RAMP 2018
- Country
- ADPT United States
- RAMP United States
- Employees
- ADPT N/A
- RAMP N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- RAMP EDP Services
- Sector
- ADPT Health Care
- RAMP Technology
- Exchange
- ADPT Nasdaq
- RAMP Nasdaq
- Market Cap
- ADPT 2.0B
- RAMP 1.8B
- IPO Year
- ADPT 2019
- RAMP 1987
- Fundamental
- Price
- ADPT $15.53
- RAMP $27.21
- Analyst Decision
- ADPT Strong Buy
- RAMP Buy
- Analyst Count
- ADPT 10
- RAMP 7
- Target Price
- ADPT $13.60
- RAMP $39.00
- AVG Volume (30 Days)
- ADPT 2.0M
- RAMP 606.6K
- Earning Date
- ADPT 11-06-2025
- RAMP 11-05-2025
- Dividend Yield
- ADPT N/A
- RAMP N/A
- EPS Growth
- ADPT N/A
- RAMP 147.00
- EPS
- ADPT N/A
- RAMP 0.22
- Revenue
- ADPT $205,216,000.00
- RAMP $764,441,000.00
- Revenue This Year
- ADPT $32.63
- RAMP $10.65
- Revenue Next Year
- ADPT $16.31
- RAMP $8.70
- P/E Ratio
- ADPT N/A
- RAMP $124.96
- Revenue Growth
- ADPT 21.60
- RAMP 12.16
- 52 Week Low
- ADPT $4.27
- RAMP $22.82
- 52 Week High
- ADPT $15.94
- RAMP $36.08
- Technical
- Relative Strength Index (RSI)
- ADPT 66.13
- RAMP 47.62
- Support Level
- ADPT $14.11
- RAMP $26.75
- Resistance Level
- ADPT $15.26
- RAMP $28.38
- Average True Range (ATR)
- ADPT 0.73
- RAMP 0.83
- MACD
- ADPT 0.12
- RAMP 0.00
- Stochastic Oscillator
- ADPT 87.90
- RAMP 26.64
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.